Changchun BCHT Biotechnology Co. (688276.SS)

CNY 26.21

(-0.53%)

Revenue Summary of Changchun BCHT Biotechnology Co.

  • Changchun BCHT Biotechnology Co.'s latest annual revenue in 2023 was 1.81 Billion CNY , up 69.08% from previous year.
  • Changchun BCHT Biotechnology Co.'s latest quarterly revenue in 2024 Q3 was 407.61 Million CNY , up 17.97% from previous quarter.
  • Changchun BCHT Biotechnology Co. reported a annual revenue of 1.07 Billion CNY in annual revenue 2022, down -10.86% from previous year.
  • Changchun BCHT Biotechnology Co. reported a annual revenue of 1.2 Billion CNY in annual revenue 2021, down -16.6% from previous year.
  • Changchun BCHT Biotechnology Co. reported a quarterly revenue of 268.05 Million CNY for 2024 Q1, down -53.58% from previous quarter.
  • Changchun BCHT Biotechnology Co. reported a quarterly revenue of 345.51 Million CNY for 2024 Q2, up 28.9% from previous quarter.

Annual Revenue Chart of Changchun BCHT Biotechnology Co. (2023 - 2017)

Historical Annual Revenue of Changchun BCHT Biotechnology Co. (2023 - 2017)

Year Revenue Revenue Growth
2023 1.81 Billion CNY 69.08%
2022 1.07 Billion CNY -10.86%
2021 1.2 Billion CNY -16.6%
2020 1.44 Billion CNY 47.73%
2019 975.66 Million CNY -4.24%
2018 1.01 Billion CNY 47.54%
2017 690.61 Million CNY 0.0%

Peer Revenue Comparison of Changchun BCHT Biotechnology Co.

Name Revenue Revenue Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 81.235%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY 37.739%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 97.601%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 88.189%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 78.8%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 76.756%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 77.967%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY -820.405%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 92.555%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY -220.417%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 89.117%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY -180.888%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 66.49%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY -110.428%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 77.939%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY 3.243%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY -48.923%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 67.201%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 88.261%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 82.564%
Nanjing Well Pharmaceutical Group Co.,Ltd. 1.15 Billion CNY -56.739%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY 51.486%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY 45.292%
Shenzhen Chipscreen Biosciences Co., Ltd. 515.78 Million CNY -251.24%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY 34.784%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 62.783%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY -212.322%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 89.857%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 76.251%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY -114.309%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 82.099%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 82.277%
Tibet Weixinkang Medicine Co., Ltd. 1.32 Billion CNY -36.971%
China National Medicines Corporation Ltd. 49.69 Billion CNY 96.355%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 82.535%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY 42.271%
ChengDu ShengNuo Biotec Co.,Ltd. 430.98 Million CNY -320.348%
Dali Pharmaceuticalco.,Ltd 87.26 Million CNY -1975.91%
Zhejiang Shengda Bio-Pharm Co., Ltd. 727.4 Million CNY -149.056%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY -520.598%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 58.136%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY 42.244%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 59.402%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY -26.442%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 95.624%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 56.702%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY -11.243%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY 41.495%
Guobang Pharma Ltd. 5.34 Billion CNY 66.134%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 672.96 Million CNY -169.206%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 62.831%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 86.322%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY 16.803%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY 12.477%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY 52.306%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.93 Billion CNY 53.918%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 932.12 Million CNY -94.358%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 84.817%
Shanghai Yizhong Pharmaceutical Co., Ltd. 360.25 Million CNY -402.881%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY 41.487%
Sichuan Huiyu Pharmaceutical Co., Ltd. 920.34 Million CNY -96.844%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY -169.74%
CanSino Biologics Inc. 345.18 Million CNY -424.838%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY 16.671%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 70.527%